Best Innovation in Supply Chain & Logistic Management
Best Innovation in Manufacturing Technology – in partnership with Pharmaceutical Technology
CEO of the Year – in partnership with PharmaBoardRoomVivek Sharma
Best Innovation in APIs and Excipients
Best Innovation in Packaging
Best Innovation in Process and Formulation Development
Excellence in Partnering & Outsourcing – in-cooperation with Pharmaceutical Outsourcing Magazine
Testimonials from 2015 winners
We would like to thank the judging panel for their recognition of our OptiShell softgel platform. OptiShell technology may provide an opportunity for formulators to develop semi-solid, extended release formulations with improved and more consistent therapeutic effectiveness.
The “hot-filling” process enables delivery of semi-solid formulations in a patient preferred dose form, while the semi-solid matrix offers extended release profiles that can reduce the maximum API concentration in the bloodstream, decrease the dosing frequency, and, therefore, potentially increase patient adherence.“
Speaking of the award, Dr. Aris Gennadios, Catalent’s President of Softgel Technologies
“As a newcomer in the Pharma Packaging Market it is just great to win with our unique BarrelDose-System the prestige CPhI Pharma Award 2015 in the category: Best Innovative in Packaging.
This single use system for liquid ingredients can be used in a wide range of pharmaceutical, medical and also animal health applications and offers new possibilities for the end-users, the fillers and manufacturers. Winning this award is a big motivation for us and proofs our efforts in developing market- and customer-oriented application systems.“
Daniel Ferrari, Director Market-Segment Healthcare
“At an exhibition such as CPhI, which attracts more than 36,000 pharma industry professionals from around the world, the importance of winning an award is really significant, particularly for a novel ingredient in this innovation-driven market. Omyapharm®, our Functionalized Calcium Carbonate, has been selected as the most innovative excipient among 20 applications from other pharmaceutical industry players and was presented with the “Best Innovation in APIs and Excipients” award.
Not only are we delighted to receive this recognition, this prestigious award also highlights the contribution of our dedicated teams and showcases the versatile benefits that calcium carbonate offers. With its extraordinary disintegration speed, we see huge market potential for Functionalized Calcium Carbonate in orally disintegrating tablets and granules. In addition, key sector stakeholders rely on CPhI to showcase the latest industry developments; winning this award not only puts Omyapharm® in the spotlight, it also brings attention to the entire Omya Group.“
Stefan Lander, Vice President Consumer Goods at Omya